Coronary artery intimal thickening and ventricular dynamics in pediatric heart transplant recipients

Anita T Cote1,2, Martin Hosking3, Christine Voss1,3

  • 1Department of Pediatrics, University of British Columbia & British Columbia Children's Hospital Research Institute, Vancouver, Canada.

Congenital Heart Disease
|September 6, 2018
PubMed

Insights

Coronary artery intimal thickening in pediatric heart transplant patients is linked to declining ventricular function. Optical coherence tomography (OCT) can identify these changes, aiding in understanding cardiac allograft vasculopathy (CAV).

Area of Science:

  • Cardiology
  • Transplantation immunology
  • Medical imaging

Background:

  • Pediatric heart transplant recipients face risks of cardiac allograft vasculopathy (CAV) and diastolic dysfunction.
  • Coronary artery intimal thickening, a hallmark of CAV, can be detected using optical coherence tomography (OCT).
  • The mechanistic link between CAV progression and declining ventricular function requires further investigation.

Purpose of the Study:

  • To assess coronary artery intimal thickening in pediatric heart transplant recipients using OCT.
  • To evaluate left ventricular (LV) strain and function in these patients.
  • To investigate the relationship between intimal thickening and ventricular dysfunction.

Main Methods:

  • Analysis of OCT images for coronary intima and media thickness and cross-sectional area (CSA) in 17 children.
  • Speckle tracking imaging (STI) of the LV to determine longitudinal strain and strain rate.
  • Standard echocardiographic measures were also obtained.

Main Results:

  • Longitudinal diastolic strain rate showed significant associations with intima thickness and CSA (r = -.497 to -.614, P = .009 to .047).
  • Intima thickness, intima/media, and intima/lumen ratios correlated with stroke volume index (Std. β = -0.487 to -0.488, P = .022 to .023).
  • These findings indicate a correlation between coronary intimal thickening and impaired ventricular function.

Conclusions:

  • Coronary artery intimal thickening is mechanistically linked to ventricular function changes post-cardiac transplantation.
  • OCT is a valuable tool for detecting early CAV changes.
  • Further research is warranted to explore therapeutic strategies targeting intimal thickening to preserve ventricular function.
Abstract

Related Concept Videos

Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
480
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
276
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
385
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
699